Across TCGA pan-cancer cohorts, FAM242A RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated FAM242A data layer.
The strongest signal is observed in mesothelioma (MESO), where higher FAM242A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM242A expression acts as an unfavorable survival marker, although some lineages such as LGG and GBM show a favorable association.
MESO, COAD, and ACC are the cancer types where FAM242A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.